Chargement en cours...
Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables
There is a growing evidence that antimalarial chloroquine could be re-purposed for cancer treatment. A dozen of clinical trials have been initiated within the past 10 years to test the potential of chloroquine as an adjuvant treatment for therapy–refractory cancers including glioblastoma, one of the...
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120043/ https://ncbi.nlm.nih.gov/pubmed/30211116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00335 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|